tiprankstipranks
Trending News
More News >
Religare Enterprises Limited (IN:RELIGARE)
:RELIGARE
India Market
Advertisement

Religare Enterprises Limited (RELIGARE) AI Stock Analysis

Compare
2 Followers

Top Page

IN:RELIGARE

Religare Enterprises Limited

(RELIGARE)

Select Model
Select Model
Select Model
Neutral 68 (OpenAI - 4o)
Rating:68Neutral
Price Target:
₹287.00
▲(13.91% Upside)
Religare Enterprises demonstrates strong financial performance with robust revenue growth and efficient cash flow management. However, high valuation metrics and challenges in profitability and return on equity present risks. The technical analysis supports a positive trend, but the stock's high P/E ratio suggests it may be overvalued.

Religare Enterprises Limited (RELIGARE) vs. iShares MSCI India ETF (INDA)

Religare Enterprises Limited Business Overview & Revenue Model

Company DescriptionReligare Enterprises Limited operates as an investment company in India and internationally. The company provides broking services in equities, currencies, and commodities; depository participant services; tax information network and income tax permanent account number facilities; and tax deduction at source/tax collection at source filing services, as well as operates as an NSDL-appointed enrolment agency for Aadhaar unique identification number and an AMFI-registered mutual fund distributor. It also offers finance for small and medium enterprises; and housing finance, including home-purchase, home construction, and home improvement loans. In addition, the company provides e-governance and financial advisory services; and issues digital signature certificate. Further, it offers health insurance services to employees of corporates, and individual customers. Additionally, the company provides critical illness, personal accident, top-up coverage, international travel, and maternity insurance products, as well as group health and personal accident insurance. Religare Enterprises Limited was incorporated in 1984 and is based in New Delhi, India.
How the Company Makes MoneyReligare Enterprises Limited generates revenue through multiple streams primarily tied to its financial services offerings. The company earns income from interest on loans provided under its lending services, fees and premiums from its health insurance products, and management fees from its asset management division. RELIGARE's growth is also supported by strategic partnerships and collaborations with financial institutions, enhancing its distribution capabilities and product offerings. Additionally, the company may engage in investments and financial advisory services, contributing further to its earnings. Key factors such as market demand for financial products, regulatory changes, and economic conditions also play a significant role in influencing the company's revenue.

Religare Enterprises Limited Financial Statement Overview

Summary
Religare Enterprises demonstrates robust revenue growth and strong cash flow management, which reinforce its operational resilience. However, challenges in profitability and low return on equity present obstacles for future growth. The balance sheet remains stable with adequate liquidity and balanced leverage.
Income Statement
78
Positive
Religare Enterprises has demonstrated robust revenue growth, with a significant increase from 2024 to 2025. The gross profit margin remains high, indicating effective cost management. However, the net profit margin has declined due to increased operating expenses, affecting overall profitability. The EBIT margin showed a positive trend, reflecting improved operational efficiency.
Balance Sheet
65
Positive
The company's balance sheet shows a moderate debt-to-equity ratio, suggesting balanced leverage. The equity ratio is healthy, indicating a strong equity base relative to total assets. However, the return on equity is low, pointing to inefficiencies in generating returns on shareholder investments. Liquidity appears sufficient with ample cash reserves.
Cash Flow
83
Very Positive
Cash flow analysis reveals strong operating cash flow, consistent with a positive trend in free cash flow, indicating solid cash generation capabilities. The operating cash flow to net income ratio is favorable, showcasing effective cash management. However, the free cash flow growth rate is modest, suggesting limited growth in cash surplus.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue59.18B59.50B50.45B36.93B24.49B16.81B
Gross Profit63.16B59.13B47.69B40.97B29.60B16.81B
EBITDA2.73B3.05B4.19B0.00-3.50B3.12B
Net Income1.05B1.25B2.33B30.82B-15.44B-5.08B
Balance Sheet
Total Assets112.29B112.29B95.77B80.94B93.53B87.26B
Cash, Cash Equivalents and Short-Term Investments10.87B10.87B10.72B8.12B25.26B16.20B
Total Debt2.33B2.33B4.43B8.41B47.94B49.40B
Total Liabilities77.92B77.92B64.08B54.16B98.85B84.28B
Stockholders Equity25.16B25.16B23.43B20.58B-9.82B-470.86M
Cash Flow
Free Cash Flow0.0015.47B14.78B14.66B15.56B13.54B
Operating Cash Flow0.0015.72B15.00B15.06B15.96B13.73B
Investing Cash Flow0.00-11.85B-13.48B-9.39B-6.89B-11.81B
Financing Cash Flow0.00-2.85B-1.56B-20.79B5.59B-3.14B

Religare Enterprises Limited Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price251.95
Price Trends
50DMA
256.93
Negative
100DMA
243.38
Positive
200DMA
246.58
Positive
Market Momentum
MACD
0.93
Negative
RSI
48.90
Neutral
STOCH
46.07
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:RELIGARE, the sentiment is Neutral. The current price of 251.95 is below the 20-day moving average (MA) of 253.20, below the 50-day MA of 256.93, and above the 200-day MA of 246.58, indicating a neutral trend. The MACD of 0.93 indicates Negative momentum. The RSI at 48.90 is Neutral, neither overbought nor oversold. The STOCH value of 46.07 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IN:RELIGARE.

Religare Enterprises Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (68)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
78
Outperform
₹67.12B5.5913.13%2.59%9.84%9.30%
69
Neutral
₹76.09B5.7112.89%1.38%10.26%1.35%
68
Neutral
₹83.31B70.8912.98%-37.79%
55
Neutral
₹64.62B-63.112.42%1.76%13.47%-115.98%
68
Neutral
$18.00B11.429.92%3.81%9.73%1.22%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:RELIGARE
Religare Enterprises Limited
251.95
-40.00
-13.70%
IN:EQUITASBNK
Equitas Small Finance Bank Ltd.
56.66
-20.56
-26.63%
IN:KTKBANK
Karnataka Bank Ltd.
171.05
-59.29
-25.74%
IN:SOUTHBANK
South Indian Bank Limited
29.08
4.81
19.82%
IN:TMB
Tamilnad Mercantile Bank Limited
423.85
-34.95
-7.62%
IN:UJJIVANSFB
Ujjivan Small Finance Bank Ltd.
44.11
3.69
9.13%

Religare Enterprises Limited Corporate Events

Religare Broking Limited’s Credit Rating Upgraded by CARE Ratings
Jul 29, 2025

Religare Enterprises Limited announced that CARE Ratings Limited has upgraded the credit rating for Religare Broking Limited’s credit facilities. This upgrade reflects improved financial and operational performance, enhancing the company’s market position and potentially benefiting stakeholders by increasing trust and investment opportunities.

Religare Enterprises Strengthens Board with New Appointments
Jul 8, 2025

Religare Enterprises Limited has announced the approval from the Reserve Bank of India for the appointment of three new Non-Executive and Non-Independent Directors, namely Mr. Arjun Lamba, Mr. Gurumurthy Ramanathan, and Mr. Suresh Mahalingam. This development, effective from July 08, 2025, is expected to enhance the governance structure of the company, potentially impacting its strategic direction and stakeholder confidence positively.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Sep 24, 2025